Lack of Socs2 expression causes the high-growth phenotype in mice

Genomics

Volumn 72, Issue 2, 2001, Pages 209-212

  Horvat, Simon ^a   Medrano, Juan F ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL OVERGROWTH; CHROMOSOME 10; CONTROLLED STUDY; CYTOKINE RELEASE; GENE MUTATION; GENE TARGETING; GROWTH REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0035280536     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6441     Document Type: Article

References (18)

1. Evidence for a major gene for rapid postweaning growth in mice
2. Diet effects on weight gain and body composition in high growth (hghg) mice
3. Interaction of human suppressor of cytokine signaling (SOCS-2) with the insulin-like growth factor-I receptor
4. Genetics of mouse growth
5. Organ and skeletal growth in mice with a major gene for rapid postweaning growth
6. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction
7. Interval mapping of high growth (hg), a major locus that increases weight gain in mice
8. A 500-kb YAC and BAC contig encompassing the high-growth deletion in mouse chromosome 10 and identification of the murine Raidd/Cradd gene in the candidate region
9. Growth hormone and insulin-like growth factor-I measurements in high growth (hg) mice
10. Gigantism in mice lacking suppressor of cytokine signalling-2
11. Effects of elevated circulating IGF-1 on the extracellular matrix in high-growth C57BL/6J mice
12. Developmental regulation of insulin-like growth factor-I and growth hormone receptor gene expression
13. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
14. A family of cytokine-inducible inhibitors of signalling
15. Morphometric analysis of skeletal muscle growth in the high growth mouse
16. Delayed myogenesis associated with muscle fiber hyperplasia in high-growth mice
17. Normal growth and development in the absence of hepatic insulin-like growth factor I